Intestinal Bacteria and Probiotics ◾ 209
3. Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J.H., Chinwalla, A.T. et al., Human
Microbiome Project, Structure, function and diversity of the healthy human microbiome, Nature, 486,
207–214, 2012.
4. Ly, N.P., Litonjua, A., Gold, D.R., and Celedon, J.C., Gut microbiota, probiotics, and vitamin D:
Interrelated exposures influencing allergy, asthma, and obesity?, J. Allergy Clin. Immunol., 127, 1087–
1094, 2011.
5. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., and Gordon, J.I., An obesityassociated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027–131, 2006.
6. Musso, G., Gambino, R., and Cassader, M., Interactions between gut microbiota and host metabolism
predisposing to obesity and diabetes, Ann. Rev. Med., 62, 361–380, 2011.
7. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., Lewis, J.D. et al.,
Linking long-term dietary patterns with gut microbial enterotypes, Science, 333, 105–108, 2011.
8. Amalaradjou, M.A.R. and Bhunia, A.K., Modern approaches in probiotics research to control foodborne pathogens, Adv. Food Nutr. Res., 67, 185–239, 2012.
9. Amalaradjou, M.A.R. and Bhunia, A.K., Bioengineered probiotics, a strategic approach to control
enteric infections, Bioengineered, 4, 2013.
10. Paton, A.W., Morona, R., and Paton, J.C., Designer probiotics for prevention of enteric infections, Nat.
Rev. Microbiol., 4, 193–200, 2006.
11. Chang, T.L.Y., Chang, C.-H., Simpson, D.A., Xu, Q., Martin, P.K., Lagenaur, L.A., Lee, P.P. et al.,
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express
functional two-domain CD4, Proc. Nat. Acad. Sci. USA, 100, 11672–11677, 2003.
12. Tarahomjoo, S., Development of vaccine delivery vehicles based on lactic acid bacteria, Mol. Biotechnol.,
51, 183–199, 2012.
13. Wells, J.M. and Mercenier, A., Mucosal delivery of therapeutic and prophylactic molecules using lactic
acid bacteria, Nat. Rev. Microbiol., 6, 349–362, 2008.
14. de Vrese, M. and Schrezenmeir, J., Probiotics, prebiotics, and synbiotics, Adv. Biochem. Eng. Biotechnol.,
111, 1–66, 2008.
15. Boyle, R.J., Robins-Browne, R.M., and Tang, M.L., Probiotic use in clinical practice: What are the
risks?, Am. J. Clin. Nutr., 83, 1256–1264, 2006.
16. Sanders, M.E., Akkermans, L.M.A., Haller, D., Hammerman, C., Heimbach, J., Hormannsperger, G.,
Vaughan, E. et al., Safety assessment of probiotics for human use, Gut Microbes, 1, 164–185, 2010.
17. Collado, M.C., Isolauri, E., Salminen, S., and Sanz, Y., The impact of probiotic on gut health, Curr.
Drug Metab., 10, 68–78, 2009.
18. Ross, R.P., Desmond, C., Fitzgerald, G.F., and Stanton, C., Overcoming the technological hurdles in
the development of probiotic foods, J. Appl. Microbiol., 98, 1410–1417, 2005.
19. Macfarlane, S., Macfarlane, G.T., and Cummings, J.H., Review article: Prebiotics in the gastrointestinal tract, Aliment. Pharmacol. Thera., 24, 701–714, 2006.
20. Stanton, C., Ross, R.P., Fitzgerald, G.F., and Van Sinderen, D., Fermented functional foods based on
probiotics and their biogenic metabolites, Curr. Opin. Biotechnol., 16, 198–203, 2005.
21. Schroeter, J. and Klaenhammer, T., Genomics of lactic acid bacteria, FEMS Microbiol. Lett., 292, 1–6,
2009.
22. O’Sullivan, O., O’Callaghan, J., Sangrador-Vegas, A., McAuliffe, O., Slattery, L., Kaleta, P., Beresford,
T. et al., Comparative genomics of lactic acid bacteria reveals a niche-specific gene set, BMC Microbiol.,
9, 2009.
3. Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J.H., Chinwalla, A.T. et al., Human
Microbiome Project, Structure, function and diversity of the healthy human microbiome, Nature, 486,
207–214, 2012.
4. Ly, N.P., Litonjua, A., Gold, D.R., and Celedon, J.C., Gut microbiota, probiotics, and vitamin D:
Interrelated exposures influencing allergy, asthma, and obesity?, J. Allergy Clin. Immunol., 127, 1087–
1094, 2011.
5. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., and Gordon, J.I., An obesityassociated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027–131, 2006.
6. Musso, G., Gambino, R., and Cassader, M., Interactions between gut microbiota and host metabolism
predisposing to obesity and diabetes, Ann. Rev. Med., 62, 361–380, 2011.
7. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., Lewis, J.D. et al.,
Linking long-term dietary patterns with gut microbial enterotypes, Science, 333, 105–108, 2011.
8. Amalaradjou, M.A.R. and Bhunia, A.K., Modern approaches in probiotics research to control foodborne pathogens, Adv. Food Nutr. Res., 67, 185–239, 2012.
9. Amalaradjou, M.A.R. and Bhunia, A.K., Bioengineered probiotics, a strategic approach to control
enteric infections, Bioengineered, 4, 2013.
10. Paton, A.W., Morona, R., and Paton, J.C., Designer probiotics for prevention of enteric infections, Nat.
Rev. Microbiol., 4, 193–200, 2006.
11. Chang, T.L.Y., Chang, C.-H., Simpson, D.A., Xu, Q., Martin, P.K., Lagenaur, L.A., Lee, P.P. et al.,
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express
functional two-domain CD4, Proc. Nat. Acad. Sci. USA, 100, 11672–11677, 2003.
12. Tarahomjoo, S., Development of vaccine delivery vehicles based on lactic acid bacteria, Mol. Biotechnol.,
51, 183–199, 2012.
13. Wells, J.M. and Mercenier, A., Mucosal delivery of therapeutic and prophylactic molecules using lactic
acid bacteria, Nat. Rev. Microbiol., 6, 349–362, 2008.
14. de Vrese, M. and Schrezenmeir, J., Probiotics, prebiotics, and synbiotics, Adv. Biochem. Eng. Biotechnol.,
111, 1–66, 2008.
15. Boyle, R.J., Robins-Browne, R.M., and Tang, M.L., Probiotic use in clinical practice: What are the
risks?, Am. J. Clin. Nutr., 83, 1256–1264, 2006.
16. Sanders, M.E., Akkermans, L.M.A., Haller, D., Hammerman, C., Heimbach, J., Hormannsperger, G.,
Vaughan, E. et al., Safety assessment of probiotics for human use, Gut Microbes, 1, 164–185, 2010.
17. Collado, M.C., Isolauri, E., Salminen, S., and Sanz, Y., The impact of probiotic on gut health, Curr.
Drug Metab., 10, 68–78, 2009.
18. Ross, R.P., Desmond, C., Fitzgerald, G.F., and Stanton, C., Overcoming the technological hurdles in
the development of probiotic foods, J. Appl. Microbiol., 98, 1410–1417, 2005.
19. Macfarlane, S., Macfarlane, G.T., and Cummings, J.H., Review article: Prebiotics in the gastrointestinal tract, Aliment. Pharmacol. Thera., 24, 701–714, 2006.
20. Stanton, C., Ross, R.P., Fitzgerald, G.F., and Van Sinderen, D., Fermented functional foods based on
probiotics and their biogenic metabolites, Curr. Opin. Biotechnol., 16, 198–203, 2005.
21. Schroeter, J. and Klaenhammer, T., Genomics of lactic acid bacteria, FEMS Microbiol. Lett., 292, 1–6,
2009.
22. O’Sullivan, O., O’Callaghan, J., Sangrador-Vegas, A., McAuliffe, O., Slattery, L., Kaleta, P., Beresford,
T. et al., Comparative genomics of lactic acid bacteria reveals a niche-specific gene set, BMC Microbiol.,
9, 2009.